Claim or Create your Free Community Profile : Sign in / Sign up
Exclusive: Human Genome agrees to GlaxoSmithKline takeover - sources
Jul 16th, 2012
(Reuters) - Human Genome Sciences Inc has agreed to be acquired by GlaxoSmithKline Plc, subject to approval of some last-minute details, for about $14 a share in cash, two sources familiar with the situation said on Sunday. The deal is expected to be announced before the U.S. stock market opens on Monday, the sources added. The price represents an increase to Glaxo's previous offer of $13 a share. Human Genome shares ended trading on Friday at $13.58. (Reporting by Greg Roumeliotis in New York) (Source: Reuters) -
By Ethan Bilby BRUSSELS (Reuters) - The European Commission plans to send a formal warning to China that it is ready to levy sanctions against telecoms equipment makers Huawei and ZTE Corp over illegal subsidies, people close to the matter said. EU trade chief Karel De Gucht is set to win support from the bloc's executive on Wednesday to send ... [Full Article]
By Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep in 1996: They transplanted genetic material from an adult cell into an egg whose own DNA had been removed. The r... [Full Article]
2Space PassportNewsCommunityMarketPlaceFree Tools
